Global Live Cell Imaging Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2025 –2032 |
Market Size (Base Year) |
USD 4.59 Billion |
Market Size (Forecast Year) |
USD 10.13 Billion |
CAGR |
|
Major Markets Players |
全球活细胞成像市场,按产品和服务(仪器、耗材、软件、服务)、应用(细胞生物学、干细胞、发育生物学、药物发现)、最终用户(制药和生物技术公司、学术和研究机构、合同研究组织)、技术(延时显微镜、光漂白后荧光恢复、高内涵筛选、荧光共振能量转移等)划分 - 行业趋势和预测至 2029 年
市场分析和规模
预测期内,活细胞成像市场预计将扩大。活细胞成像是一种允许科学家实时研究细胞及其结构、功能和特性的技术。该方法彻底改变了对分子相互作用、细胞、蛋白质和各种活动的研究。由于活细胞成像比固定细胞成像更不容易受到实验伪影的影响,因此活细胞成像市场拥有坚实的基础。
Data Bridge Market Research 分析,活细胞成像市场规模在 2021 年为 34.1 亿美元,到 2029 年将飙升至 62.1 亿美元,预计在 2022 年至 2029 年的预测期内复合年增长率为 7.78%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
报告范围和市场细分
报告指标 |
细节 |
预测期 |
2022 至 2029 年 |
基准年 |
2021 |
历史岁月 |
2020(可定制为 2014 - 2019) |
定量单位 |
收入(单位:十亿美元)、销量(单位:台)、定价(美元) |
涵盖的领域 |
产品和服务(仪器、耗材、软件、服务)、应用(细胞生物学、干细胞、发育生物学、药物研发)、最终用户(制药和生物技术公司、学术和研究机构、合同研究组织)、技术(延时显微镜、光漂白后荧光恢复、高内涵筛选、荧光共振能量转移、其他) |
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
涵盖的市场参与者 |
Bio-Rad Laboratories, Inc. (U.S), Agilent Technologies (U.S), Cytiva (U.S), Blue-Ray Biotech Corp. (Taiwan), CytoSMART Technologies (Netherlands), Curiosis Inc. (South Korea), Carl Zeiss AG (U.S), General Electric (U.S), Leica Microsystems (Germany), Thermo Fisher Scientific Inc. (U.S), Perkin Elmer (U.S), Danaher (U.S), Bruker (U.S), Nikon Corporation (Japan), and Olympus Corporation (Japan) |
Market Opportunities |
|
Market Definition
The study of cells in real time using pictures obtained from screening devices and microscopes is known as live cell imaging. Scientists' approaches to studying proteins, molecular interactions, and internal structures of cells, as well as cellular processes and biological activities, have changed as a result of technological advancements. Instead of reviewing the photos of fixed cells, they can watch cells to acquire a more in-depth insight.
Live Cell Imaging Market Dynamics
Drivers
- Increasing research and development activities
Increasing research and development investment is likely to boost market growth. Other factors such as rising cancer incidence, rising adoption of high-content screening approaches in drug discovery, increasing demand for better and faster diagnostic facilities, and technological advancement are likely to propel the live cell imaging market forward from 2022 to 2029.
- Approval of high-content screening techniques
The adoption of high-content screening techniques, large government funding for cell-based research, and rising cancer occurrences worldwide are driving the global live cell imaging market. Market players can benefit from the adoption of high-content screening methods for primary screening and the use of live cell imaging in personalised medicine.
- Advancement Technologies
According to a poll conducted by Drug Discovery World Spring, nearly 21% of researchers favour and employ live cell imaging, with 31% planning to do so in the future. Furthermore, 38% of respondents said they would like to use live cell kinetic HCS imaging in the future. The capacity to automate the incubation and picture capture of any live cell analyser is the most significant feature for researchers. Second, they place a premium on the equipment's ability to track live cells. Over the projected period, more advancements in equipment technology are likely to meet these criteria and increase their utility.
Opportunities
The UK and Europe will face a major lack of lab skills over the next decade, according to Healthcare-in-Europe.com, an online platform that delivers trends in medical technology, new procedures, and breakthroughs in medical research. Medical laboratories will be among the most affected. Furthermore, according to the Gatsby Foundation's analysis, the UK will require an additional 700,000 technicians to sustain the economy by the end of 2030. As a result, in the next years, a scarcity of experienced workers is projected to stifle market expansion.
Restraints/Challenges
High cost of the high-content screening systems and lack of skilled and trained professionals is expected to hinder the market growth in the forecast period of 2022 to 2029.
This live cell imaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the live cell imaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 impact on Live Cell Imaging Market
COVID-19 has no effective treatment in the form of vaccinations or antiviral medicines at this time, hence patients are treated symptomatically. According to the WHO, 70 vaccine candidates are now being developed, with three of them already being tested in human trials. Many experts throughout the world are studying SARS-CoV-2, the virus that causes COVID-19, at the forefront of the COVID-19 outbreak. Researchers can use live cell imaging tools, such as sophisticated microscopy equipment, to analyse cellular behaviour during viral research. To generate vaccines, biomedical research necessitates the processing of massive amounts of data. As a result, prominent live cell imaging system vendors including Leica Microsystems in Germany and CytoSMART Technologies in the Netherlands have contributed live cell imaging systems to COVID-19 researchers.
Recent Development
- In December 2020, Horizon Discovery was purchased for an unknown sum by PerkinElmer Inc., a US-based diagnostics company with detection, imaging, informatics, and service capabilities.
Global Live Cell Imaging Market Scope
活细胞成像市场根据产品、应用和技术进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。
产品
- 设备
- 消耗品
- 软件
应用
- 细胞生物学
- 发育生物学
- 干细胞和药物研发
- 其他的
技术
- 延时显微镜
- 光漂白后荧光恢复 (FRAP)
- 荧光共振能量转移(FRET)
- 高内涵筛选(HCS)
- 其他的
活细胞成像 市场区域分析/见解
对活细胞成像市场进行了分析,并按国家、产品、应用和技术提供了上述市场规模的见解和趋势。
活细胞成像市场报告涵盖的国家包括北美的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
北美因其高投资率和技术完善的基础设施而占据主导地位。该地区的研究公司具有技术意识,因此愿意投资高成本的设备。
由于这些成像技术在药物发现和个性化医疗中的应用日益广泛,预计亚太地区将在预测期内呈现最快的增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和活细胞成像 市场份额分析
活细胞成像市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对活细胞成像市场的关注有关。
活细胞成像市场的一些主要参与者包括:
- Bio-Rad Laboratories, Inc.(美国)
- 安捷伦科技(美国)
- Cytiva (美国)
- 藍光生技股份有限公司 (台灣)
- CytoSMART Technologies(荷兰)
- Curiosis Inc. (韩国)
- 卡尔蔡司公司(美国)
- 通用电气(美国)
- 徕卡显微系统(德国)
- 赛默飞世尔科技公司(美国)
- Perkin Elmer(美国)
- 丹纳赫(美国)
- 布鲁克 (美国)
- 尼康公司(日本)
- 奥林巴斯株式会社(日本)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.